 Correlation occult clonogenic leukemia drug sensitivity relapse autologous bone marrow transplantation initial complete remission rates majority patients acute myeloid leukemia AML adults acute lymphocytic leukemia ALL relapse therapeutic results acute leukemia biology minimal residual leukemia therapy responsible relapse biologic relevance vitro assay clonogenic leukemia leukemia units CFU-L measure minimal residual leukemia consecutive patients acute leukemia complete remission autologous bone marrow transplantation BMT cyclophosphamide-based therapy CFU-L pretransplant remission marrows patients patients AML ALL Clonal rearrangements identical patients overt leukemia available occult CFU-L patients ALL DNA analysis None uncultured pretransplant remission marrows ALL patients clonal gene rearrangements vitro sensitivity occult CFU-L results outcome patients sensitivity occult CFU-L factor relapse BMT actuarial probability relapse patients CFU-L sensitive patients CFU-L resistant factor CFU-L sensitivity type leukemia CFU-L AML patients sensitive CFU-L ALL patients CFU-L represent occult leukemia CFU-L assay means biology minimal residual leukemia therapeutic results patients acute leukemia